SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Computers - SoftwareAnnouncement - Persistent
Persistent
BSE: 533179NSE: PERSISTENTISIN: INE262H01013

27th-Feb-2013 11:40Source: BSE

Persistent - Persistent Systems Launches PaxPharma, Compliance-based Design to Print Automation for the Pharmaceutical Industry

Persistent Systems Ltd has informed BSE regarding a Press Release dated February 26, 2013 titled "Persistent Systems Launches PaxPharma, Compliance-based Design to Print Automation for the Pharmaceutical Industry". Persistent Systems announced the immediate availability of PaxPharma, a compliance-based, Design to Print (D2P) automation solution designed specifically for pharmaceutical packaging and product lifecycle management (PLM).

More Announcements on:

3rd-Jul-2015 11:50Source: NSE

Persistent Systems Limited

3rd-Jul-2015 11:23Source: BSE

Persistent - Updates on Subsidiary

30th-Jun-2015 09:34Source: NSE

Persistent Systems Limited

27th-Jun-2015 16:17Source: BSE

Persistent - AGM on July 24, 2015

26th-Jun-2015 23:19Source: BSE

Persistent - Q1 results on July 25, 2015

23rd-Jun-2015 17:58Source: BSE

Persistent - Business Update for Q1 FY16

15th-Jun-2015 12:49Source: NSE

Persistent Systems Limited

15th-Jun-2015 09:56Source: NSE

Persistent Systems Limited

1 2 3 4 5 Next >>
Board Meeting (Persistent)

Meeting Date

Remark

2015-07-25

Quarterly Results

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(July 02, 2015)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo
2400

Powerful mix of both trader and investor packs with timely expert advice.

Technical
1429

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental
1429

For all investors looking to unearth stocks that are poised to move.

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.